5774
S. Ko et al. / Tetrahedron Letters 46(2005) 5771–5774
Shan, R.; Velazquez, C.; Knaus, E. E. J. Med. Chem. 2004,
7, 254; (h) Sawada, Y.; Kayakiri, H.; Abe, Y.; Mizutani,
T.; Inamura, N.; Asano, M.; Hatori, C.; Arsmori, I.; Oku,
Tetrahedron Lett. 2002, 43, 879; (d) Firouzabadi, H.;
4
Iranpoor, N.; Sobhani, S. Tetrahedron Lett. 2002, 43,
3653; (e) Yadav, J. S.; Reddy, B. V. S.; Reddy, M. S.;
Prasad, A. R. Tetrahedron Lett. 2002, 43, 9703; (f)
Bandgar, B. P.; Shaikh, K. A. Tetrahedron Lett. 2003,
44, 1959; (g) Das, B.; Banerjee, J.; Ramu, R.; Pal, R.;
Ravindranath, N.; Ramesh, C. Tetrahedron Lett. 2003, 44,
5465; (h) Saeeng, R.; Sirion, U.; Sahakitpichan, P.; Isobe,
M. Tetrahedron Lett. 2003, 44, 6211; (i) Ji, S.-J.; Wang, S.-
Y.; Zhang, Y.; Loh, T.-P. Tetrahedron 2004, 60, 2051; (j)
Yadav, J. S.; Reddy, B. V. S.; Shubashree, S.; Sadashiv, K.
Tetrahedron Lett. 2004, 45, 2951; (k) Phukan, P. J. Org.
Chem. 2004, 69, 4005; (l) Phukan, P. Tetrahedron Lett.
2004, 45, 4785; (m) Sun, J.; Dong, Y.; Wang, X.; Wang, S.;
Hu, Y. J. Org. Chem. 2004, 69, 8932; (n) Bhosale, R. S.;
Bhosale, S. V.; Bhosale, S. V.; Wang, T.; Zubaidha, P. K.
Tetrahedron Lett. 2004, 45, 9111; (o) Ke, B.; Qin, Y.; He,
Q.; Huang, Z.; Wang, F. Tetrahedron Lett. 2005, 46, 1751;
(p) Banik, B. K.; Fernandez, M.; Alvarez, C. Tetrahedron
Lett. 2005, 46, 2479.
T.; Tanaka, H. J. Med. Chem. 2004, 47, 2853.
2
3
. (a) Buhler, F. R.; Kiowski, W. J. Hypertens. 1987, S3, 5;
b) Reid, J. L.; Meredith, P. A.; Pasanisi, F. J. Cardiovasc.
(
Pharmacol. 1985, S18, 7.
. (a) Godfraid, T.; Miller, R.; Wibo, M. Pharmacol. Rev.
1
1
986, 38, 321; (b) Sausins, A.; Duburs, G. Heterocycles
988, 27, 269; (c) Mager, P. P.; Coburn, R. A.; Solo, A. J.;
Triggle, D. J.; Rothe, H. Drug Des. Discovery 1992, 8, 273;
d) Mannhold, R.; Jablonka, B.; Voigdt, W.; Schoenafin-
(
ger, K.; Schravan, K. Eur. J. Med. Chem. 1992, 27, 229.
. (a) Klusa, V. Drugs Future 1995, 20, 135; (b) Bretzel, R.
G.; Bollen, C. C.; Maeser, E.; Federlin, K. F. Am. J.
Kidney Dis. 1993, 21, 53; (c) Bretzel, R. G.; Bollen, C. C.;
Maeser, E.; Federlin, K. F. Drugs Future 1992, 17, 465; (d)
Boer, R.; Gekeler, V. Drugs Future 1995, 20, 499.
. Love, B.; Sander, K. M. J. Org. Chem. 1965, 30, 1914.
. (a) Hantzsch Ber. Dtsch. Chem. Ges. 1888, 21, 942; (b)
Hantzsch, A. Ber. Dtsch. Chem. Ges. 1890, 23, 1747; (c)
Wiley, R. H.; England, D. C.; Behr, L. C. In Organic
Reactions; John Wiley, 1951; Vol. 6, p 367; (c) Dondoni,
A.; Massi, A.; Minghini, E.; Bertolasi, V. Tetrahedron
4
5
6
13. (a) For examples: Banik, B. K.; Mukhopadhyay, C.;
Venkatraman, M. S.; Becker, F. F. Tetrahedron Lett.
1998, 39, 7243; (b) Banik, B. K.; Zegrocka, O.; Banik, I.;
Hackfeld, L.; Becker, F. F. Tetrahedron Lett. 1999, 40,
6731; (c) Banik, B. K.; Zegrocka, O.; Becker, F. F. J.
Chem. Res. (S) 2000, 321; (d) Mukhopadhyay, C.; Becker,
F. F.; Banik, B. K. J. Chem. Res. (S) 2001, 28; (e)
Firouzabadi, H.; Iranpoor, N.; Hazarkhani, H. J. Org.
Chem. 2001, 66, 7527; (f) Yadav, J. S.; Reddy, B. V. S.;
Sabitha, G.; Reddy, G. S. K. K. Synthesis 2000, 1532; (g)
Basu, M. K.; Samajdar, M. K.; Becker, F. F.; Banik, B. K.
Synlett 2002, 319; (h) Yadav, J. S.; Reddy, B. V. S.; Rao,
C.; Sabitha, V.; Reddy, M. J. Synthesis 2003, 247.
2004, 60, 2311.
7
. (a) Khadikar, B. M.; Gaikar, V. G.; Chitnavis, A. A.
Tetrahedron Lett. 1995, 36, 8083; (b) Ohberg, L.; West-
man, J. Synlett 2001, 1296; (c) Agarwal, A.; Chauhan, P.
M. S. Tetrahedron Lett. 2005, 46, 1345.
8
9
. (a) Ji, S.-J.; Jiang, Z.-Q.; Lu, J.; Loh, T.-P. Synlett 2004,
8
2
31; (b) Sridhar, R.; Perumal, P. T. Tetrahedron 2005, 61,
465.
. (a) Phillips, A. P. J. Am. Chem. Soc. 1949, 71, 4003; (b)
Anderson, G. J. R.; Berkelhammer, G. J. Am. Chem. Soc.
14. Unpublished results.
1
958, 80, 992; (c) Singh, H.; Chimni, D. S. S.; Kumar, S.
15. A typical experimental procedure for the preparation of
5a: A 10 mL round-bottomed flask charged with benzal-
dehyde 1a (0.106 g, 1.0 mmol), 1,3-cyclohexanedione 2
Tetrahedron 1995, 51, 12775; (d) Gordeev, M. F.; Patel, D.
V.; Gordon, E. M. J. Org. Chem. 1996, 61, 924; (e)
Breitenbucher, J. G.; Figliozzi, G. Tetrahedron Lett. 2000,
(0.112 g, 1.0 mmol), ethyl acetoacetate
3
(0.130 g,
4
1, 4311; (f) Liang, J.-C.; Yeh, J.-L.; Wang, C.-S.; Liou,
S.-F.; Tasi, C.-H.; Chen, I.-J. Bioorg. Med. Chem. 2002,
0, 719; (g) Miri, R.; Niknahad, H.; Vesal, Gh.; Shafiee, A.
1.0 mmol), ammonium acetate 4 (0.077 g, 1.0 mmol) and
iodine (0.076 g, 0.3 mmol) followed by few drops (5–6
drops) of ethanol. The mixture was then stirred at room
temperature until the reaction was completed (2.5 h,
monitored by TLC). The reaction mixture was treated
with aq Na S O solution, extracted into ethyl acetate
1
IL Farmaco 2002, 57, 123; (h) Dondoni, A.; Massi, A.;
Minghini, E.; Sabbatini, S.; Bertoasi, V. J. Org. Chem.
2003, 68, 6172; (i) Dondoni, A.; Massi, A.; Minghini, E.;
2
2
3
Bertoasi, V. Tetrahedron 2004, 60, 2311; (j) Tewari, N.;
Dwivedi, N.; Tripathi, R. P. Tetrahedron Lett. 2004, 45,
(2 · 20 mL) and the crude product (99%) was recrystal-
lized from ethanol to give the product 5a as a yellow solid
1
9011; (k) Moseley, J. D. Tetrahedron Lett. 2005, 46, 3179.
(0.304 g, 98% Y) (mp: 240–241 ꢁC. H NMR (CDCl3,
1
1
1
0. Sabitha, G.; Reddy, G. S. K. K.; Reddy, Ch. S.; Yadav, J.
S. Tetrahedron Lett. 2003, 44, 4129.
1. Wang, L.-M.; Sheng, J.; Zhang, L.; Han, J.-W.; Fan, Z.;
Tian, H.; Qian, C.-T. Tetrahedron 2005, 61, 1539.
400 MHz): d 1.18 (t, 3H, J = 6.8 Hz), 1.80–2.10 (m, 2H),
2.30–2.44 (m, 7H), 4.05 (q, 2H, J = 6.8 Hz), 5.09 (s, 1H),
6.07 (s, 1H), 7.10 (t, 1H, J = 7.6 Hz), 7.20 (t, 2H,
1
3
J = 7.6 Hz), 7.30 (d, 2H, J = 7.6 Hz). C NMR (CDCl3,
2. (a) For examples: Kim, K. M.; Ryu, E. K. Tetrahedron
Lett. 1996, 37, 1441; (b) Firouzabadi, H.; Iranpoor, N.;
Hazarkhani, H. J. Org. Chem. 2001, 66, 7527; (c)
Ramalinga, K.; Vijayalakshmi, P.; Kaimal, T. N. B.
100 MHz): d 14.16, 19.34, 21.01, 27.46, 36.38, 37.00, 59.78,
106.06, 113.46, 125.99, 127.90, 127.98, 143.30, 147.12,
+
149.58, 167.41. HRMS calcd for C19
311.1521, found: 311.1526.
H21NO
3
(M )